(Q85193972)
Statements
Nuclear factor-kappa B inhibition can enhance therapeutic efficacy of 131I on the in vivo management of differentiated thyroid cancer (English)
Zhaowei Meng
Shanshan Lou
Jian Tan
Ke Xu
Qiang Jia
Wei Zheng
12 October 2012